New Top 25 Big Pharma is born

News that Organon has been bought by Indian generics giant Sun Pharma creating a new company that will join the top ranks of industry was our top story this week.

Once the deal goes through the new Top 25 pharma will boast a footprint in 150 countries with 18 large markets expected to generate more than US$100 million a year in revenue. It's a big win for shareholders too. Find out why in: Big Pharma goes under the hammer

Outcomes from the PBAC's March meeting were released this week with positive outcomes for just about everyone. But even though 23 out of 26 submissions won recommendations, scratch the surface and all is not as well as it seems. Find out why in: PBAC greenlights new drugs